Table 1.

Sociodemographic and clinical data from the sample of patients assessed 6–9 months and 12–15 months after infection with SARS-CoV-2.

	Patients included in the study
	N = 33
Mean age in years (± SD)	61.30 (± 10.98)
Education level (1/2/3)	1/13/19
Sex (F/M)	7/26
Number of patients who required intermediate/intensive care in the acute phase	11/22
Mean days of hospitalization (± SD)	30.16 (± 25.91)
Mean days between positive RT-PCR test and collection of immunological data (± SD)	1.26 (± 2.85)
Diabetes (yes/no)	6/27
History of respiratory disorders (yes/no)	7/26
History of cardiovascular disorders (yes/no)	8/25
History of neurological disorders (yes/no)	0/33
History of psychiatric disorders (yes/no)	0/33
History of cancer (yes/no)	0/33
History of severe immunosuppression (yes/no)	0/33
History of developmental disorders (yes/no)	0/33

Education level: 1 = compulsory schooling, 2 = post-compulsory schooling, and 3 = university degree or equivalent. Encephalopathy observed in the acute phase.

RT-PCR reverse transcription polymerase chain reaction, SD standard deviation, Sex F female, M mal.